Home
Conditions
Basal Ganglia Diseases

Clinical trial condition

Basal Ganglia Diseases

Explore clinical trials studying Basal Ganglia Diseases. Study availability and eligibility vary by location and protocol.

4,055 public trials 751 recruiting studies

Refine in advanced search Browse all conditions

Basal Ganglia Diseases trial results

Recruiting

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease

NCT06965374

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: IRCCS Oasi SS. Troina /ID# 273507 Troina, Enna, Italy

Istituto Neurologico Mediterraneo Neuromed S.P.A. - Irccs /Id# 272695 Pozzilli, Isernia, Italy

ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO /ID# 272949 Milan, Milano, Italy

Fondazione IRCCS Istituto Neurologico Carlo Besta /ID# 273225 Milan, Milano, Italy

View all 19 locations

View Trial Details

Recruiting

Exoskeleton-Assisted Mobility in Aging and in Parkinson's Disease

NCT07567482

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +8 more
Locations: TechCare Research Lab - CISSS de l'Outaouais Gatineau, Quebec, Canada

View Trial Details

Recruiting

AID-FOG: Artificial Intelligence-Driven Freezing of Gait Detection in the Home

NCT07580612

Conditions: Artifical Intelligence, Basal Ganglia Diseases, Brain Diseases, +11 more
Locations: Department of Rehabilitation Sciences Leuven, Belgium

Sports Science and Neurorehabilitation Hamburg, Germany

Center for the study of movement, cognition and mobility Tel Aviv, Israel

View Trial Details

Recruiting

Pain in Parkinson's Disease: Exploration of the Serotonin System in Positron Emission Tomography (PET [18F]-MPPF)

NCT06008704

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Centre Hospitalier Universitaire de Toulouse Toulouse, Haute-Garonne, France

View Trial Details

Recruiting

This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.

NCT07102342

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Cornell University Weill Medical College New York, United States

View Trial Details

Recruiting

Remote Delivery of a Mindfulness-based Intervention for Tics

NCT06408662

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
Locations: Johns Hopkins University School of Medicine Baltimore, Maryland, United States

View Trial Details

Recruiting

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

NCT07005180

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Quest Research Institute Farmington Hills, Michigan, United States

View Trial Details

Recruiting

Patient-Specific 3D Action Observation Training in Parkinson's Disease

NCT07250672

Conditions: 3d Recording, Action Obervation Training, Basal Ganglia Diseases, +10 more
Locations: Abant Izzet Baysal University Faculty of Health Science Bolu, Turkey (Türkiye)

View Trial Details

Recruiting

Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease

NCT05568498

Conditions: Basal Ganglia Diseases, Behavior, Behavioral Symptoms, +10 more
Locations: Pacific Parkinson's Research Centre Vancouver, British Columbia, Canada

View Trial Details

Recruiting

Investigations of Dementia in Parkinson Disease

NCT02763683

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations: Washington University in St. Louis St Louis, Missouri, United States

View Trial Details

Basal Ganglia Diseases

Basal Ganglia Diseases trial results

Related conditions